Growth hormone secretagogue

Ipamorelin

Ghrelin-receptor agonist (GHRP)

No human approval — clinic/anecdote
Based on expert consensus from publicly available videos plus public FDA/regulatory status — not medical advice. Peptides are prescription territory; consult a physician before using anything here.

The Verdict

A 'cleaner' GH peptide (less appetite spike than alternatives) per Koniver, but it has no FDA approval or large human trials — clinic-anecdote territory, and the GH/longevity caution applies.

The Evidence

FDA / Legal Status

Not FDA-approved

Human Evidence

GH-receptor-specific with milder hunger effect; clinician-protocol use, no large human trials

Sport / Doping

Banned in sport

Safety Flags

  • No large human trials; GH-elevation cancer risk
  • Koniver caution: keep doses low (~100 mcg) and don't read side effects as efficacy

Who Covers It

Andrew Huberman
Andrew Huberman

Other experts in the panel had no substantive coverage of this peptide — we don't guess their position.

Want the deep dive on Ipamorelin?

This grade is free. Pro unlocks chat with the full expert dataset — ask about dosing, stacks, sourcing, and the exact citations behind every claim.

Cancel anytime

Go Deeper